Kadcyla (ado-trastuzumab emtansine) - Roche
Jivadco (trastuzumab duocarmazine) - Byondis, Medac
Enhertu (fam-trastuzumab deruxtecan-nxki) - Daiichi Sankyo, AstraZeneca
Perjeta (pertuzumab) - Roche
https://atgproductions.net/atgclients/sabcs/2023_SABCS_Abstract_Report-12-1-23_Compressed.pdf
 
James Pearson1; Adeel Khan2; Talvinder Bhogal1; Helen Wong2; Andrea Law2; Samantha Mills3; Nuria Santamaria2; Joanne Cliff2; Douglas Errington2; Allison Hall2; Clare Hart2; Zafar Malik2; Raj Sripadam2; Helen Innes2; Helen Flint2; Gabriella Langton2; Eliyaz Ahmed2; Jill Bishop2; Richard Jackson4; Carlo Palmieri1
 
Nov 4, 2023
 
Prev Next